Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAOIB in Mild Cognitive Impairment
NCT04736355Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jan 2020
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of daoib in Mild Cognitive Impairment (MCI), sponsored by Chang Gung Memorial Hospital. Started Jan 2020; status: completed.
02
Drugs
daoib
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT04736355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04736355.